Stryker (NYSE:SYK | SYK Price Prediction) is one of the quieter success stories in large-cap healthcare, and Reddit has barely noticed. Shares are down 9.46% over the past week, sitting at $337.29, and social sentiment on Reddit remains subdued. The cause of recent bearish chatter is a single viral post, not a business collapse.
One thread in r/stocks about a cyberattack attributed to an Iranian-linked hacker group called Handala drove that bearish chatter. The post, titled “Stryker (SYK) has lost almost $6 Billion since Iranian-linked hacker group Handala halted their operations globally,”, gathered 107 upvotes and 46 comments over roughly 24 hours. That single post is responsible for the bearish sentiment in the dataset. This is concentrated panic, not distributed conviction.
Stryker (SYK) has lost almost $6 Billion since Iranian-linked hacker group Handala halted their operations globally.
by
u/beefstewdudeguy in
r/stocks
Why Reddit’s Fear Doesn’t Match Stryker’s Fundamentals
The business itself tells a different story. Stryker just crossed $25 billion in annual revenue for the first time, posting 11.4% revenue growth in Q4 2025 and beating earnings estimates in all four quarters of 2025. Adjusted operating margins expanded at least 100 basis points for the second consecutive year. Free cash flow grew to $4.28 billion, up nearly 23% year over year. These are not the numbers of a company in distress.
The Reddit sentiment driving bearish scores reflects three things:
- The cyberattack is an operational disruption, not structural business deterioration
- Activity on Reddit remains classified as “low”, meaning broader retail engagement with SYK is minimal
- Analyst consensus remains constructive, with a consensus price target of $424.89 against today’s price near $337, and 22 buy or strong buy ratings versus zero sell ratings
What SYK Investors Should Actually Watch
CEO Kevin Lobo described entering 2026 with “significant momentum” and guided for 8% to 9.5% organic growth and adjusted EPS of $14.90 to $15.10 for the full year. The Mako robotic surgery platform set installation records in Q4, and the Inari Medical acquisition is delivering, with the Vascular segment up 58.1% year over year. The real question is how quickly operations normalize from the reported disruption and whether management addresses it directly in upcoming communications. Reddit’s fear is loud right now, but it is coming from a single post, not a crowd.
Top Gaining Stocks
Top Losing Stocks